Clinical study to evaluate the benefits of satavari ksheerapaka and ksheerabala siropichu in mild to moderate postpartum depression

“An open label single arm clinical study to evaluate the combined effect of internal administration of satavari kshirapaka and kshirabala taila siropichu in mild to moderate post partum depression ? - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062151

Enrollment

Registered

2024-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O906- Postpartum mood disturbance

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age between eighteen to fortyyears, primi or multigravida without labour complications, Epds score greater than 13, hamitons score greater than eight and eighteen, patients from four weeks to tenmonths are included

Exclusion criteria

Exclusion criteria: EPDS score less than 13, Hamiltons score greater than 18, ICD10 diagnostic criteria with severe episodes are excluded, Previous history of psychiatric disorder, under antidepressent medications, Active suicidal,homicidal and infanticide thoughts during prescreening.

Design outcomes

Primary

Measure	Time frame
Improvement in mild-moderate symptoms associated with Post- Partum Depression assessed by using EPDS Scale,HDRS-17 Scale and ICD-10 Diagnostic CriteriaTimepoint: 8th day and 30th day	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Dafini David

Amrita School of Ayurveda

shaithyaraj@ay.amrita.edu9495434862

Outcome results